Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy.
Koutaïssoff S, Wellmann D, Coucke P, Ozsahin M, Pampallona S, Mirimanoff RO. Koutaïssoff S, et al. Among authors: pampallona s. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1151-6. doi: 10.1016/s0360-3016(99)00307-7. Int J Radiat Oncol Biol Phys. 1999. PMID: 10613307 Free article. Clinical Trial.
Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
Ares C, Popowski Y, Pampallona S, Nouet P, Dipasquale G, Bieri S, Ozsoy O, Rouzaud M, Khan H, Miralbell R. Ares C, et al. Among authors: pampallona s. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):656-63. doi: 10.1016/j.ijrobp.2008.11.023. Epub 2009 Feb 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19250768
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
Leyvraz S, Perey L, Rosti G, Lange A, Pampallona S, Peters R, Humblet Y, Bosquée L, Pasini F, Marangolo M. Leyvraz S, et al. Among authors: pampallona s. J Clin Oncol. 1999 Nov;17(11):3531-9. doi: 10.1200/JCO.1999.17.11.3531. J Clin Oncol. 1999. PMID: 10550151 Clinical Trial.
(106)Ruthenium brachytherapy for retinoblastoma.
Abouzeid H, Moeckli R, Gaillard MC, Beck-Popovic M, Pica A, Zografos L, Balmer A, Pampallona S, Munier FL. Abouzeid H, et al. Among authors: pampallona s. Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):821-8. doi: 10.1016/j.ijrobp.2007.11.004. Epub 2008 Jan 22. Int J Radiat Oncol Biol Phys. 2008. PMID: 18207660
Prognostic factors in colorectal cancer.
Cerottini JP, Caplin S, Pampallona S, Givel JC. Cerottini JP, et al. Among authors: pampallona s. Oncol Rep. 1999 Mar-Apr;6(2):409-14. doi: 10.3892/or.6.2.409. Oncol Rep. 1999. PMID: 10023012
74 results